Dinesh C Paliwal - Net Worth and Insider Trading

Dinesh C Paliwal Net Worth

The estimated net worth of Dinesh C Paliwal is at least $3 Million dollars as of 2024-04-25. Dinesh C Paliwal is the Director of RTX Corp and owns about 20,288 shares of RTX Corp (RTX) stock worth over $2 Million. Dinesh C Paliwal is the Director of Bristol-Myers Squibb Co and owns about 22,109 shares of Bristol-Myers Squibb Co (BMY) stock worth over $992,690. Dinesh C Paliwal is also the Director of Raytheon Co and owns about 2,795 shares of Raytheon Co (RTN) stock worth over $326,903. Besides these, Dinesh C Paliwal also holds ADT Inc (ADT) . Details can be seen in Dinesh C Paliwal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dinesh C Paliwal has not made any transactions after 2020-10-29 and currently still holds the listed stock(s).

Transaction Summary of Dinesh C Paliwal

To

Dinesh C Paliwal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dinesh C Paliwal owns 4 companies in total, including Bristol-Myers Squibb Co (BMY) , RTX Corp (RTX) , and Raytheon Co (RTN) among others .

Click here to see the complete history of Dinesh C Paliwal’s form 4 insider trades.

Insider Ownership Summary of Dinesh C Paliwal

Ticker Comapny Transaction Date Type of Owner
BMY Bristol-Myers Squibb Co 2020-06-15 director
RTX RTX Corp 2020-10-29 director
RTN Raytheon Co 2020-04-03 director
JCI Johnson Controls International PLC 2011-03-09 director

Dinesh C Paliwal Latest Holdings Summary

Dinesh C Paliwal currently owns a total of 4 stocks. Among these stocks, Dinesh C Paliwal owns 20,288 shares of RTX Corp (RTX) as of October 29, 2020, with a value of $2 Million and a weighting of 60.68%. Dinesh C Paliwal owns 22,109 shares of Bristol-Myers Squibb Co (BMY) as of June 15, 2020, with a value of $992,690 and a weighting of 29.26%. Dinesh C Paliwal also owns 2,795 shares of Raytheon Co (RTN) as of April 30, 2018, with a value of $326,903 and a weighting of 9.64%. The other 1 stocks ADT Inc (ADT) have a combined weighting of 0.42% among all his current holdings.

Latest Holdings of Dinesh C Paliwal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RTX RTX Corp 2020-10-29 20,288 101.46 2,058,420
BMY Bristol-Myers Squibb Co 2020-06-15 22,109 44.90 992,690
RTN Raytheon Co 2018-04-30 2,795 116.96 326,903
ADT ADT Inc 2012-09-28 2,189 6.50 14,218

Holding Weightings of Dinesh C Paliwal


Dinesh C Paliwal Form 4 Trading Tracker

According to the SEC Form 4 filings, Dinesh C Paliwal has made a total of 1 transactions in RTX Corp (RTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in RTX Corp is the acquisition of 9,532 shares on October 29, 2020, which cost Dinesh C Paliwal around $499,572.

According to the SEC Form 4 filings, Dinesh C Paliwal has made a total of 1 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bristol-Myers Squibb Co is the acquisition of 9,174 shares on June 15, 2020, which cost Dinesh C Paliwal around $499,983.

According to the SEC Form 4 filings, Dinesh C Paliwal has made a total of 0 transactions in Raytheon Co (RTN) over the past 5 years. The most-recent trade in Raytheon Co is the acquisition of 1,219 shares on April 30, 2018, which cost Dinesh C Paliwal around $249,895.

More details on Dinesh C Paliwal's insider transactions can be found in the Insider Trading History of Dinesh C Paliwal table.

Insider Trading History of Dinesh C Paliwal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dinesh C Paliwal Trading Performance

GuruFocus tracks the stock performance after each of Dinesh C Paliwal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dinesh C Paliwal is 10.81%. GuruFocus also compares Dinesh C Paliwal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dinesh C Paliwal within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dinesh C Paliwal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dinesh C Paliwal

Average Return

10.87%

Average return per transaction

Outperforming Transactions

40%

2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.74 10.81 9.18 10.87 16.23 8.02
Relative Return to S&P 500(%) 5.99 2.69 -1.15 -11.4 8.86 -5.34

Dinesh C Paliwal Ownership Network

Ownership Network List of Dinesh C Paliwal

No Data

Ownership Network Relation of Dinesh C Paliwal


Dinesh C Paliwal Owned Company Details

What does Bristol-Myers Squibb Co do?

Who are the key executives at Bristol-Myers Squibb Co?

Dinesh C Paliwal is the director of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Commercial Officer Christopher S. Boerner , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .

Bristol-Myers Squibb Co (BMY) Insider Trades Summary

Over the past 18 months, Dinesh C Paliwal made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 45,419 shares made by Ann Powell Judge , a net sale of 96,295 shares made by Rupert Vessey , and a net purchase of 5,071 shares made by Christopher S. Boerner .

In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 382,446 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 368,875 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bristol-Myers Squibb Co Insider Transactions

No Available Data

Dinesh C Paliwal Mailing Address

Above is the net worth, insider trading, and ownership report for Dinesh C Paliwal. You might contact Dinesh C Paliwal via mailing address: 5454 W 110th Street, Overland Park Ks 66211.

Discussions on Dinesh C Paliwal

No discussions yet.